chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vomiting; Fever; Soreness; 12 hours after vaccination there was muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 21Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and it was not reported if the patient had allergies to medications, food, or other products. Concomitant medications included cyanocobalamin (B 12), zinc (MANUFACTURER UNKNOWN), fish oil (OMEGA 3), unspecified Multivitamin and Algae Oil ; all taken from an unknown date for an unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 13:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 22:30, 12 hours after vaccination, the patient experienced muscle soreness and on 22Apr2021 at 01:30, 15 hours after vaccination there was vomiting, fever and soreness that lasted for 12 hours. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle soreness was recovered on an unknown date in Apr2021 and the clinical outcome of the events vomiting, fever and soreness was recovered on 22Apr2021 at 13:30.  No follow-up attempts are needed. No further information is expected.
I had no symptoms until one week later, 1/28/21. I began getting itchy, redness and minor swelling at injection site. I spoke to a doctor and he prescribed  Twice daily, of Doxycycline Hyclate. He said it was unusual to develop symptoms at this time so it could be a delayed  reaction or an infection. Airing on the side of caution, he prescribed the antibiotic. My temperature is normal and I have no other symptoms.  I?m also taking Benadryl to relieve itching. I?m on the medication for the next ten days.
Patient developed erythema, warmth, tenderness, over area where vaccines given (cellulitis).  Started on Augmentin.
Information has been received a physician concerning a 5 year old male with no known drug allergies, who on 07/03/1996 was vaccinated with the first dose of varicella vaccine. There was no illness at the time of vaccination. On 03/20/2001, the pt presented in the physician's office with "about 15 vesicular lesion and no other symptoms." The physician reported the pt had "chickenpox mild." Subsequently on 03/20/2001, the pt recovered from the chicken pox. The physician also reported on the pt's sister who had a similar experience following vaccination with varicella vaccine. Additional info is not expected.
Patient presented to ED with chest pain and subsequently had elevated troponins warranting him to be transferred to a higher level of care.
Red rash around injection site. Slight itching, slightly sore to touch. A week after injection. Has faded over last few days. No treatment, just monitoring.
Sore arm in the injection arm on the first dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm in the injection arm on the first dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm in the injection arm on the first dose). At the time of the report, MYALGIA (Sore arm in the injection arm on the first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Aug-2021, Heart rate increased: 137-154 bpm (High) 137-154 bpm during standing and walking..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant use was reported. No treatment medication was reported.   This case was linked to MOD-2021-284724 (Patient Link).
Red, hot or warm to touch, my arm felt sore and this is what made me look at it.  It was a larger red mark and I drew a circle around it and its spread outside the circle.
Patient's arm was red and warm to the touch at injection site. Arm was also swollen and sore.
Patient woke up with pain  loss of motion in left hand that subsides as day progresses.  Irregular bowel movement.  Occasionally dizzy spells.  Woke up with sharp pain in outer corner of right eye on 10/30/2021.
Numbness on the left arm with a reaction about 1-2 inches to the right of the injection site. Both knee joints formed a plaque after receiving the vaccine.  These conditions were not present prior to vaccination
Shaky, felt faint, hyperventilated  Rash on neck Emt checked vitals Heart racing all else good
Information has been received from a nurse concerning an unspecified number of unspecified patients of unknown age and gender. No current or historical conditions were reported. On unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ (dose, Lot# and expiration date were not reported) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as the reporter was not allowed to be contacted.
A report was received from a health care professional on 12/11/03 concerning a 21 month old male vaccinee who inadvertently received 0.25ml Fluvirin vaccine on 12/09/03. On 12/9/03 the vaccinee received Fluvirin vaccine. No signs or symptoms of an adverse event were reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
This spontaneous report was received from a Certified Medical Assistant and refers to an unspecified number of patients of unknown age and gender. No pertinent medical history, drug reactions or allergies and concomitant medications were reported. On unknown dates, an unspecified number of patients received doses of RECOMBIVAX HB (lot # L010595, expiration date 12-NOV-2016; lot # K024552. expiration date 22-OCT-2016; dose, frequency, indication and route of administration were not reported) that were improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Waves of aches in major joints, weakness in hands, recurring often, initialy each reoccurrence lessened in severity. Symptoms persisted for at least 10 months. Doctor performed many tests. He believed my symptoms were a reaction to the LYMErix vaccine and stated that I did not have Lyme disease. Follow-up with doctor. Follow up 01/13/05: Date of adverse event changed from 08/23/1999 to 07/_/99. Still gets occasional pain in thigh.
5/4/22-Patient brought to Emergency Department by EMS secondary to bilateral leg weakness leading to a fall.  Reported legs feeling weak for past week, hard time getting up or standing, veering to R when walking.  No headache focal weakness or problems with speech.  Balance problems persisted and resulted in fall.  Able to get herself up.  MRI and head CT interpreted by Neurology per H&P   "...stroke had happened probably a week, and there is evidence of bleeding but more petechial hemorrhage but probably from an underlying ischemic stroke."
pregnant patient received 1st dose of Moderna Covid 19 vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant patient received 1st dose of Moderna Covid 19 vaccine) in a 32-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included BUPROPION for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Jul-2020 and the estimated date of delivery was 21-Apr-2021. On 21-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant patient received 1st dose of Moderna Covid 19 vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 21-Jan-2021, EXPOSURE DURING PREGNANCY (pregnant patient received 1st dose of Moderna Covid 19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Aug-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was previously pregnant and delivered 2 babies by full term birth on 27-Feb-2016 and 08-Jun-2018. No treatment information was provided.
red itchy rash below injection site, 3 1/4 " by 2" with a small white bump
patient was given only the diluent portion of the pentacel vaccine/ No AE; Initial information received on 14-Aug-2020 regarding an unsolicited valid non-serious case from the other health care professional.   This case involves a 4 months old male patient who was given only the diluent portion of the suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (0.5 ml, lot UJ189AAA and expiration date: 06-Apr-2021) via unknown route in the right thigh as prophylactic vaccination on 12-Aug-2020 (product preparation issue).  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for prophylactic vaccination on 12-Aug-2020.  It was an actual medication error case due to inappropriate reconstitution technique (latency same day).  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
A nurse reported that a 39 year old patient received an injection of Tetanus Diphtheria Toxoids Adsorbed, Purogenated on 06/16/00 and subsequently developed an injection site reaction characterized by redness, warmth, and swelling. The reaction persisted for at least 1 week. This is 1 of 3 patients from this facility who developed an injection site reaction following receipt of 2 different lots of Tetanus Diphtheria Toxoids Adsorbed, Purogenated.
During the night following recording the vaccine, I awoke around 2am with chills and excessive shivering that lasted about 2 hours until around 4am.
VERY SWOLLEN UPPER ARM WITH REDNESS AND ITCHYNESS THE DAY AFTER THE VACCINE.
Patient developed redness, swelling, and inflammation in the right arm after administration of the PNEUMOVAX 23 vaccine.  She said it started at site of injection then moved down her arm past her elbow.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Chills-Medium, Additional Details: patient noticed blisters and rash appearing at site of injection and also on the chest, it didn't get better and she decided to call the pharmacy, patient was recommended benadryl and tylenol pain relief and was also recommended to check with md
No adverse event; Vaccine administered after beyond use date (07-Jul-2022); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (07-Jul-2022)) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (07-Jul-2022)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (07-Jul-2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date (07-Jul-2022)).    No concomitant medication was reported.  Reportedly, the vaccine BUD date was 07-Jul-2022.  No treatment information was provided.
Left upper arm has raised reddish blotches beneath the vaccination site (shoulder). They do not itch, but they are warm to the touch. Arm beneath them is slightly hard and swollen. I noticed them the night of 5/14, but it's possible they were present earlier - I wasn't looking at the arm from a few hours after the vaccination (afternoon of 5/13) until now.
acute allergic diffuse urticarial rash (hives).  Itching.   responded very well to OTC benadryl.  almost completed resolved the next day at doctor's visit
I received the third GARDASIL vaccine three days ago and have had bad side effects with body aches, fever, headaches, and fatigue. The symptoms came on about 14 hours after receiving the vaccine.
On Jan 31, had a scratchy feeling on L back, under the bra area and on L arm (upper, back).  It was irritating, itchy and slightly painful.  During the night, the same symptoms.  A little more painful today, also noted red marks on the back area and arm.  Appears to be Shingles.  Also yesterday I had a slight discomfort in my Left chest.  That remains today.
Second shot the swelling happened much more quickly and larger; Second shot more arm soreness; Some movement limitation; This is a spontaneous report received from a contactable consumer (patient reported for herself). A 39-years-old female non-pregnant patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, Formulation: solution for injection, Batch/Lot number: ER8734), via an unspecified route of administration, administered in left arm on 13Apr2021 at 17:15 hours (at the age of 39-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications in 2 weeks included sertraline hydrochloride (ZOLOFT) and birth control medications. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, Formulation: solution for injection, Batch/Lot number: EP7534), via an unspecified route of administration, administered in left arm on 23Mar2021 at 17:00 hours as (at the age of 38-years-old) dose 1, single for COVID-19 immunisation and experienced swelling of lymph nodes and surrounding tissue (big lump) on shoulder near collarbone only on the side of the injection. The patient received no other vaccine in four weeks. The patient has no COVID prior to vaccination and was not tested for COVID post vaccination. On 14Apr2021 at 07:00, the patient experienced second shot the swelling happened much more quickly and larger, second shot more arm soreness, and some movement limitation. The patient received no treatment for the adverse events. The outcome of the events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Swollen lips/lips became swollen; Nasal congestion; Extremely tired; Allergic reaction to the Aflluria vaccine; Progressed to head ached; Feelings of nausea; This spontaneous case, initially received from other non-health professional on 02-Oct-2018, concerns a 50-year-old, adult male patient.  The patient had no historical condition. The patient did not receive any concomitant medication.  On 26-Sep-2018, the patient was administered Afluria Quadrivalent [influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 01944621A (reported as 019446218) and expiry date: 25-May-2018] for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.  On the same day, within 3-4 hours after the vaccination, the patient developed allergic reaction to the suspect vaccine. The patient felt extremely tired, then progressed to head ache, then feeling of nausea. The patient's lips became swollen with nasal congestion. The events lasted for around 20 hours.  On 27-Sep-2018 (reported as within 24 hrs), the patient recovered from the events.  The reporter assessed the case as non-serious and the causality as related.  Follow-up received from other health professional on 01-Nov-2018: Dose, route of administration and anatomical location of the suspect vaccine was added in the product tab. The event weight fluctuation' was deleted from the event tab as the reporter clarified it to be "extremely tired" instead of "extreme weight". Narrative and case comment were amended accordingly.; Reporter's Comments: A 50-year-old, male patient developed allergic reaction to the suspect vaccine that included tiredness, headache, nausea, swollen lips and nasal congestion, 3-4 hours after the administration of Afluria Quadrivalent. The company assessed the causality as related due to plausible temporal relationship between the events and the suspect vaccine.
The following morning after receiving his 2nd dose, he noticed 2 fluid filled lesions on his let hand and one small one on his rught side of his news. He reports that they itch.
Pt has not experienced and did not experience any signs or symptoms before. during, or after the vaccine was given. No treatment plan advised per Medical Director
This medically confirmed spontaneous report (initial receipt: 23-Oct-2012) concerns a 1-year-old male patient. On 12-Oct-2012 the patient received a flu vaccine (manufacturer, brand name and batch number were not provided). On the same day the patient also received MMR II (batch number: 1644Z) injection at a dose of 0.5 mL for 'prevention of pneumococcal virus' (as reported), HIB and PREVNAR. On 12-Oct-2012 the patient had full body rashes, but no itching. The event outcome was recovered.
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. On an unknown date these unknown number of patients were vaccinated with VAQTA (lot#, dose, route not reported) that had been improperly stored. Concomitant medications were not provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative: per NO, chills have improved but are still present and  COVID toes (diagnosed in urgent care) still look the same. NO  states all COVID tests have been negative.
36 hours of alternating fever (up to 103) and chills, muscle and body aches, and raging headache.
9 days after receiving MMR developed urticarial rash. Patient also reports aches, pains, with chills & nausea started 11 days after vaccination. He is also reporting swelling in the throat and fever. Physician exam notes skin urticaria only. Patient has been using BENADRYL & CLARITIN, ranitidine added 4/4. Patient continues to feel symptoms at this time.
Shingles (Herpes Zoster) symptoms began just over 24 hours following the administration of the vaccine.  Initial symptoms were pain and numbness radiating from right hip / gluteal area down right leg.  Pain/tingling/numbness spread across belly area in the following days.  Patient remained unaware it could be shingles until June 1, 2021 when multiple patches of blisters appeared down lower right leg.  Medical help sought the following day June 2, 2021.  Acyclovir 800mg (5 times daily) was prescribed for 7 days.  To date, some soreness remains at the initial site as well as some sensitivity across belly area.
Pt vaccinated with DTP/OPV/HIB/MMR found apneic in crib on 06OCT90.
Rash and itching began 2 hr after administration. Used ZYRTEC/BENADRYL.
Pt developed swelling and redness in her left arm after the injection on 6/5/18, felt tired and dizzy yesterday 6/6/18, but now improved. Treatment: monitor for increase swelling, pain, fever or blister. RTC if any concerns. Cool compresses and rest arm. Cephalexin 500mg capsule-1 capsule 3x/day PO x 7 days.